Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Acta Neuropathol. 2020 Aug 4;140(4):449–461. doi: 10.1007/s00401-020-02199-7

Fig 1.

Fig 1

Alzheimer’s Disease Neuropathological Change (ADNC) scores in N = 208 cases from Penn with a primary clinicopathological diagnosis of PD or DLB. a Number of subjects and % of whole cohort at each level of ADNC. b Representative immunohistochemical sections (160X) demonstrating Lewy body aSyn pathology alone in anterior cingulate (left panel, in red), concomitant Aβ (brown) and aSyn (red) pathology in anterior cingulate (middle panel), and Aβ (red) and tau NFT (brown) pathology in middle frontal cortex (right panel). aSyn pathology was detected with the MJFR13 antibody against phosphorylated aSyn. Aβ pathology was detected with the NAB228 antibody, and tau NFT’s were detected with the 17028 rabbit polyclonal anti-tau antibody.